Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of acute kidney injury after laparoscopic partial nephrectomy in elderly patients
ChiCTR2100055100Phase 4Recruiting
- Sponsor
- The Third Medical Center of PLA General Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in acute kidney failure (AKF) (2 arms), sponsored by The Third Medical Center of PLA General Hospital. Primary endpoints: Serum creatinine and Serum cystatin C. Started Jan 2022; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2100055100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100055100.